From Science 2 0 to Pharma 3 0

Science 2.0 uses the resources of Web 2.0 to communicate between scientists, and with the general public. Web 3.0, in turn, has brought disruptive technologies such as semantic search, cloud computing and mobile applications into play. The term Pharma 3.0 anticipates the future relationship between drug makers and doctors with their patients in light of such technology. From Science 2.0 to Pharma 3.0 examines these developments, discussing the best and worst of Web 2.0 in science communication and health. Successes such as the Open Access phenomena and also less successful networks are covered. This title is divided into three parts. The first part considers the Web 2.0 revolution, and the promise of its impact on science communication and the state of Science 2.0. The second part looks at impact on Pharma and Health, including attempts to utilise digital in Pharma. The last part looks at the promising disruptive technologies of Web 3.0, including semantic search in biomedicine and enterprise platforms. The book concludes by looking forward to developments of ‘3.0’ in Pharma and STM publishing. Gives a global overview of success and failure in Science 2.0 Presents useful stories and lessons learned Gives a clear view of how semantic search is present in science platforms and its potential in STM publishing

Produk Detail:

  • Author : Hervé Basset
  • Publisher : Elsevier
  • Pages : 286 pages
  • ISBN : 1780633750
  • Rating : 4/5 from 21 reviews
CLICK HERE TO GET THIS BOOKFrom Science 2 0 to Pharma 3 0

From Science 2.0 to Pharma 3.0

From Science 2.0 to Pharma 3.0
  • Author : Hervé Basset,David Stuart,Denise Silber
  • Publisher : Elsevier
  • Release : 10 September 2012
GET THIS BOOKFrom Science 2.0 to Pharma 3.0

Science 2.0 uses the resources of Web 2.0 to communicate between scientists, and with the general public. Web 3.0, in turn, has brought disruptive technologies such as semantic search, cloud computing and mobile applications into play. The term Pharma 3.0 anticipates the future relationship between drug makers and doctors with their patients in light of such technology. From Science 2.0 to Pharma 3.0 examines these developments, discussing the best and worst of Web 2.0 in science communication and health. Successes such as the Open Access phenomena and

The Changing Status of Women in West Bengal, 1970-2000

The Changing Status of Women in West Bengal, 1970-2000
  • Author : Jasodhara Bagchi
  • Publisher : SAGE Publications India
  • Release : 07 January 2005
GET THIS BOOKThe Changing Status of Women in West Bengal, 1970-2000

This important and comprehensive volume vividly depicts the current status of women and girls in West Bengal. The analysis has been conducted in the framework of the socio-economic and politico-cultural ambience that has characterized the state in recent decades. The contributors highlight both areas of strength and vulnerability and clearly demonstrate that the status of women cannot be conceived as monolithic or static—it has many facets and is in a state of constant flux. The analysis of macro data

Pharmaceutical Industry and Public Policy in Post-reform India

Pharmaceutical Industry and Public Policy in Post-reform India
  • Author : Reji K. Joseph
  • Publisher : Routledge
  • Release : 24 July 2015
GET THIS BOOKPharmaceutical Industry and Public Policy in Post-reform India

This book examines the impact of economic reforms in India on the pharmaceutical industry and access to medicines. It traces the changing production and trade pattern of the industry, research and development (R&D) preferences and strategies of Indian pharmaceutical firms, patent system alongside pricing policy measures and their shortcomings. It also analyses the public health financing system in India driven largely by out-of-pocket expenditure — about 60 per cent — and characterised by very high share of medicines in total health expenditure.